Documents
Application Sponsors
ANDA 203455 | INVAGEN PHARMS | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Application Products
001 | TABLET;ORAL | 20MG | 0 | NADOLOL | NADOLOL |
002 | TABLET;ORAL | 40MG | 0 | NADOLOL | NADOLOL |
003 | TABLET;ORAL | 80MG | 0 | NADOLOL | NADOLOL |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2015-12-18 | |
Submissions Property Types
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
003 | Prescription | AB |
CDER Filings
INVAGEN PHARMS
cder:Array
(
[0] => Array
(
[ApplNo] => 203455
[companyName] => INVAGEN PHARMS
[docInserts] => ["",""]
[products] => [{"drugName":"NADOLOL","activeIngredients":"NADOLOL","strength":"20MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"NADOLOL","activeIngredients":"NADOLOL","strength":"40MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"NADOLOL","activeIngredients":"NADOLOL","strength":"80MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"12\/18\/2015","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2015\\\/203455Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2015-12-18
)
)